New York City-based investment firm Silver Lake Partners announced on Dec. 2 it has sold financial trading technology company IPC Systems Inc., in Jersey City, N.J., to Centerbridge Partners, a private investment firm also in New York City, for about $1.2 billion.
$50M Drug Acquisition for Merck
Merck & Co., in Whitehouse Station, N.J., on Nov. 24 announced it has paid about $50 million to acquire the license to develop and sell rVSV-EBOV, a potential Ebola vaccine currently in first-stage trials, from fellow pharmaceutical company New Link Genetics of Ames, Iowa.
Storage Facility Sells for $2.97M
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]